{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:12:14Z","timestamp":1756383134880},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>The aim was to evaluate baseline demographic, clinical, and laboratory characteristics, treatment modalities, and outcome of children with idiopathic hypereosinophilic syndrome (HES) followed up in our center. Children who fulfilled the criteria of idiopathic HES followed up at Hacettepe University Faculty of Medicine, Pediatric Hematology Department between June 2004 and October 2013 were included in this study. Medical records of all children with idiopathic HES were reviewed to obtain regarding data. The mean age of 6 children with idiopathic HES was 52.8\u00b144.3 months (13 to 132 mo) at diagnosis. Among 6 children with idiopathic HES; 2 had pulmonary involvement; 1 had cardiac and pulmonary involvement and splenomegaly; 1 had cardiac involvement and hepatosplenomegaly; 1 had cardiac and central nervous system involvement; and 1 had skin involvement. The mean follow-up duration was 36.5\u00b131.4 months. Methyl prednisolone (MP) was used for the first-line therapy. Complete response was achieved with MP in 3 children. All steroid responsive children are alive; whereas 3 children who did not respond to MP had expired. In conclusion, cardiac and pulmonary involvement is the major causes of mortality in HES. Resistance to steroid therapy indicates poor prognosis.<\/jats:p>","DOI":"10.1097\/mph.0000000000000668","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T20:32:13Z","timestamp":1471638733000},"page":"539-543","source":"Crossref","is-referenced-by-count":5,"title":["Hypereosinophilic Syndrome: Hacettepe Experience"],"prefix":"10.1097","volume":"38","author":[{"given":"Betul","family":"Tavil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"Ayta\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sule","family":"Unal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baris","family":"Kuskonmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Gumruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mualla","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ajh.22062","article-title":"World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management","volume":"86","author":"Gotlib","year":"2011","journal-title":"Am J Hematol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","article-title":"Eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"New Engl J Med"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic","volume":"133","author":"Pardanani","year":"2006","journal-title":"Br J Haematol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2004.09.014","article-title":"Pediatric hypereosinophilic syndrome (HES) differs from adult HES","volume":"146","author":"Katz","year":"2005","journal-title":"J Pediatr"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2141.2010.08394.x","article-title":"Molecular characterization of paediatric idiopathic hypereosinophilia","volume":"151","author":"Rapanotti","year":"2010","journal-title":"Br J Haematol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.leukres.2012.05.025","article-title":"Hypereosinophilic syndrome in children","volume":"36","author":"van Grotel","year":"2012","journal-title":"Leuk Res"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12098-012-0821-x","article-title":"Idiopathic hypereosinophilic syndrome in children: 3 cases with review of literature","volume":"80","author":"Kanthila","year":"2013","journal-title":"Indian J Pediatr"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.76.2.231","article-title":"Thrombocytosis in chronic eosinophilic pneumonia","volume":"76","author":"Brezis","year":"1979","journal-title":"Chest"},{"key":"R14-20230918","first-page":"837","article-title":"Chronic eosinophilic pneumonia associated with thrombocytosis and pleural effusion","volume":"142","author":"d\u2019Amours","year":"1990","journal-title":"CMAJ"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ajh.23293","article-title":"World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Gotlib","year":"2012","journal-title":"Am J Hematol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2257.2001.00345.x","article-title":"The analysis of eosinophil and lymphocyte phenotype following single dose of high-dose methylprednisolone in two siblings with marked hypereosinophilia","volume":"23","author":"U\u00e7kan","year":"2001","journal-title":"Clin Lab Haematol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1705437","article-title":"Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript","volume":"38","author":"Halaburda","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.1995.tb03404.x","article-title":"Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome","volume":"90","author":"Fukushima","year":"1995","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201610000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:04:43Z","timestamp":1695009883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201610000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000668","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}